DOI: 10.1055/s-00034924

Nuklearmedizin - NuclearMedicine

LinksSchließen

Referenz

Massart C, Origiazzi J, Maugendre D.
Clinical validity of a new commercial method for detection of TSH-receptor binding antobodies in sera from patients with Graves’ disease treated with antithyroid drugs.

Clin Chim Acta 2001;
304: 39-47.

Bibliographische Angaben herunterladen

Aufrufen in: